Athanasios Galanis - Concepedia

Author

Athanasios Galanis

Also Known As

A. Galanis, A. S. Galanis, A.S. Galanis, Athanasios Galanis, Athanassios Galanis, Athanassios S Galanis, Athanassios S. Galanis, Galanis, A., Galanis, A.S., Galanis, Athanasios

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Patras Universitat de Barcelona National and Kapodistrian University of Athens Italian Institute of Technology Center for Nanotechnology Innovation

About

Athanasios Galanis is an author at University of Patras specializing in natural sciences, engineering, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	8	8	593
2	Engineering	7	7	410
3	Medicine	6	6	366
4	Arts	1	1	13
5	Health Sciences	1	1	45

Athanasios Galanis

Publications

949

Citations

H-Index

Page 1

	Year	Citations
Fast electron diffraction tomography Mauro Gemmi, Maria G. I. La Placa, Athanasios Galanis, Journal of Applied Crystallography X-ray CrystallographyCrystal StructureEngineeringMicroscopyElectron Diffraction	2015	158
Potent Bombesin-like Peptides for GRP-Receptor Targeting of Tumors with <sup>99m</sup>Tc: A Preclinical Study Berthold A. Nock, Anastasia Nikolopoulou, Athanasios Galanis, Journal of Medicinal Chemistry Potent Bombesin-like PeptidesPeptide EngineeringPeptide SciencePeptide TherapeuticsTumor Biology	2004	154
Vaccination of Patients With Advanced Non–Small-Cell Lung Cancer With an Optimized Cryptic Human Telomerase Reverse Transcriptase Peptide I. Bolonaki, Elsa Papadimitraki, Despoina Aggouraki, Journal of Clinical Oncology	2007	107
Solid-Phase Peptide Synthesis in Water Using Microwave-Assisted Heating Athanasios Galanis, Fernando Alberício, Morten Grøtli Organic Letters Solid-phase Peptide SynthesisBioorganic ChemistrySolid-phase SynthesisBiochemistryEngineering	2009	90
Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivatives Samar Mowafy, Athanasios Galanis, Zainab M. Doctor, Bioorganic & Medicinal Chemistry Medicinal ChemistryThioureido-quinazoline DerivativesMutant Egfr InhibitorsBiochemistryMedicine	2016	60
A Phase I Study of the Optimized Cryptic Peptide TERT<sub>572Y</sub> in Patients with Advanced Malignancies Dimitriοs Mavroudis, Irena Bolonakis, Sébastien Cornet, Oncology	2006	55
Crystal Structures of Two Important Pharmaceuticals Solved by 3D Precession Electron Diffraction Tomography Partha Pratim Das, Enrico Mugnaioli, Stavros Nicolopoulos, Organic Process Research & Development X-ray CrystallographyCrystal StructureEngineeringMicroscopyChemistry	2018	51
Structure-function discrimination of the N- and C- catalytic domains of human angiotensin-converting enzyme: implications for Cl- activation and peptide hydrolysis mechanisms Andreas G. Tzakos, Athanasios Galanis, Georgios A. Spyroulias, Protein Engineering Design and Selection Protein ChemistryProtein AssemblyBiochemistryProtein FoldingMembrane Transport	2003	49
[99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results Anastasia Nikolopoulou, Eleni Stathopoulou, Athanasios Galanis, European Journal of Nuclear Medicine and Molecular Imaging EngineeringOncologic ImagingTheranosticsPreclinical ResultsRadiopharmaceutical Therapy	2007	45
Amyloid fibril formation propensity is inherent into the hexapeptide tandemly repeating sequence of the central domain of silkmoth chorion proteins of the A-family Vassiliki A. Iconomidou, Georgios D. Chryssikos, V. Gionis, Journal of Structural Biology Central DomainProtein SecretionProtein FunctionBiochemistryProtein Assembly	2006	41

Page 1